- Home
- SNTI vs PPBT Comparison
SNTI vs PPBT Comparison
Compare SNTI & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- PPBT
- Stock Information
- Founded
- SNTI 2016
- PPBT 2010
- Country
- SNTI United States
- PPBT Israel
- Employees
- SNTI N/A
- PPBT N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- PPBT Biotechnology: Pharmaceutical Preparations
- Sector
- SNTI Health Care
- PPBT Health Care
- Exchange
- SNTI Nasdaq
- PPBT Nasdaq
- Market Cap
- SNTI 14.1M
- PPBT 9.2M
- IPO Year
- SNTI N/A
- PPBT N/A
- Fundamental
- Price
- SNTI $2.18
- PPBT $5.41
- Analyst Decision
- SNTI
- PPBT Strong Buy
- Analyst Count
- SNTI 0
- PPBT 2
- Target Price
- SNTI N/A
- PPBT $126.50
- AVG Volume (30 Days)
- SNTI 19.2K
- PPBT 38.7K
- Earning Date
- SNTI 11-11-2024
- PPBT 11-19-2024
- Dividend Yield
- SNTI N/A
- PPBT N/A
- EPS Growth
- SNTI N/A
- PPBT N/A
- EPS
- SNTI N/A
- PPBT N/A
- Revenue
- SNTI $338,000.00
- PPBT N/A
- Revenue This Year
- SNTI $254.47
- PPBT N/A
- Revenue Next Year
- SNTI $169.66
- PPBT N/A
- P/E Ratio
- SNTI N/A
- PPBT N/A
- Revenue Growth
- SNTI N/A
- PPBT N/A
- 52 Week Low
- SNTI $1.52
- PPBT $5.13
- 52 Week High
- SNTI $8.48
- PPBT $36.00
- Technical
- Relative Strength Index (RSI)
- SNTI 34.39
- PPBT 37.91
- Support Level
- SNTI $2.08
- PPBT $5.20
- Resistance Level
- SNTI $2.46
- PPBT $8.60
- Average True Range (ATR)
- SNTI 0.25
- PPBT 0.69
- MACD
- SNTI -0.11
- PPBT -0.09
- Stochastic Oscillator
- SNTI 10.48
- PPBT 22.19
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.